Sriveda Boyalakuntla/LinkedIn
Jan 4, 2026, 21:39
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn:
”Grateful for the opportunity to attend ASH25 and present our work on abbreviated DOAC therapy for pediatric infection-associated cerebral venous sinus thrombosis.
I’m honored to have received an Abstract Achievement Award for this work.
A huge thank you to Dr. Riten Kumar for the incredible mentorship and guidance throughout this project without whose support this experience would not be possible.
I learned so much from the conference, listening to experts in hematology, meeting inspiring professionals, and engaging with the hematology community.
I’m excited to carry these insights forward in my future endeavors.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’